

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 7.78085043 |
| 2 | negative regulation of B cell apoptotic process (GO:0002903) | 5.82124941 |
| 3 | daunorubicin metabolic process (GO:0044597) | 5.45572221 |
| 4 | polyketide metabolic process (GO:0030638) | 5.45572221 |
| 5 | doxorubicin metabolic process (GO:0044598) | 5.45572221 |
| 6 | mature B cell differentiation involved in immune response (GO:0002313) | 5.02928985 |
| 7 | regulation of penile erection (GO:0060405) | 4.90526686 |
| 8 | metallo-sulfur cluster assembly (GO:0031163) | 4.83349073 |
| 9 | iron-sulfur cluster assembly (GO:0016226) | 4.83349073 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.80324231 |
| 11 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.77975592 |
| 12 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.76184014 |
| 13 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.61676198 |
| 14 | nucleotide salvage (GO:0043173) | 4.54300140 |
| 15 | purine nucleotide salvage (GO:0032261) | 4.45740060 |
| 16 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.38864067 |
| 17 | hyperosmotic salinity response (GO:0042538) | 4.36246353 |
| 18 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.34262238 |
| 19 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.34262238 |
| 20 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.32837791 |
| 21 | deoxyribonucleotide catabolic process (GO:0009264) | 4.15301348 |
| 22 | grooming behavior (GO:0007625) | 4.05432591 |
| 23 | negative regulation of mRNA processing (GO:0050686) | 4.00182177 |
| 24 | deoxyribose phosphate catabolic process (GO:0046386) | 3.99424674 |
| 25 | DNA unwinding involved in DNA replication (GO:0006268) | 3.98503458 |
| 26 | aggressive behavior (GO:0002118) | 3.93423359 |
| 27 | Peyers patch development (GO:0048541) | 3.92484835 |
| 28 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.92484835 |
| 29 | prostanoid biosynthetic process (GO:0046457) | 3.80382631 |
| 30 | prostaglandin biosynthetic process (GO:0001516) | 3.80382631 |
| 31 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.76176160 |
| 32 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.74277377 |
| 33 | viral mRNA export from host cell nucleus (GO:0046784) | 3.67478565 |
| 34 | positive regulation of prostaglandin secretion (GO:0032308) | 3.63386729 |
| 35 | establishment of integrated proviral latency (GO:0075713) | 3.63065875 |
| 36 | UV protection (GO:0009650) | 3.62731602 |
| 37 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.62287340 |
| 38 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.61759502 |
| 39 | negative regulation of RNA splicing (GO:0033119) | 3.58401955 |
| 40 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.55434845 |
| 41 | deoxyribose phosphate metabolic process (GO:0019692) | 3.48384728 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 3.45951470 |
| 43 | chaperone-mediated protein transport (GO:0072321) | 3.41948806 |
| 44 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.41850422 |
| 45 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.38185182 |
| 46 | purine nucleobase biosynthetic process (GO:0009113) | 3.35919454 |
| 47 | regulation of mitochondrial translation (GO:0070129) | 3.34278423 |
| 48 | heme biosynthetic process (GO:0006783) | 3.28018450 |
| 49 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.26697041 |
| 50 | mitochondrial calcium ion transport (GO:0006851) | 3.26562161 |
| 51 | dosage compensation (GO:0007549) | 3.26039725 |
| 52 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.23735352 |
| 53 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.21928327 |
| 54 | pentose-phosphate shunt (GO:0006098) | 3.20982130 |
| 55 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.20937843 |
| 56 | establishment of viral latency (GO:0019043) | 3.20359310 |
| 57 | rRNA transcription (GO:0009303) | 3.19534671 |
| 58 | negative regulation of mRNA metabolic process (GO:1903312) | 3.16400604 |
| 59 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.15614263 |
| 60 | regulation of B cell apoptotic process (GO:0002902) | 3.15103021 |
| 61 | DNA ligation (GO:0006266) | 3.13625119 |
| 62 | deoxyribonucleotide metabolic process (GO:0009262) | 3.12648771 |
| 63 | autophagic vacuole fusion (GO:0000046) | 3.10441892 |
| 64 | nucleobase biosynthetic process (GO:0046112) | 3.09801342 |
| 65 | glucose catabolic process (GO:0006007) | 3.08692551 |
| 66 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.08010496 |
| 67 | ribosome biogenesis (GO:0042254) | 3.07896878 |
| 68 | transcription from mitochondrial promoter (GO:0006390) | 3.07588324 |
| 69 | galactose catabolic process (GO:0019388) | 3.07508479 |
| 70 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.06296373 |
| 71 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.04446075 |
| 72 | nucleoside salvage (GO:0043174) | 3.02723547 |
| 73 | branched-chain amino acid catabolic process (GO:0009083) | 3.00859338 |
| 74 | pinocytosis (GO:0006907) | 3.00659580 |
| 75 | histone arginine methylation (GO:0034969) | 3.00412745 |
| 76 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.99411835 |
| 77 | pyrimidine nucleoside salvage (GO:0043097) | 2.98707844 |
| 78 | pyrimidine-containing compound salvage (GO:0008655) | 2.98707844 |
| 79 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.96952178 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 2.95958474 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 2.95958474 |
| 82 | ncRNA 3-end processing (GO:0043628) | 2.92067204 |
| 83 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.91612858 |
| 84 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.90944144 |
| 85 | nuclear envelope reassembly (GO:0031468) | 2.90420374 |
| 86 | mitotic nuclear envelope reassembly (GO:0007084) | 2.90420374 |
| 87 | oxidative phosphorylation (GO:0006119) | 2.90332062 |
| 88 | morphogenesis of an epithelial fold (GO:0060571) | 2.88389637 |
| 89 | negative regulation of cell aging (GO:0090344) | 2.88013464 |
| 90 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.87190407 |
| 91 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.85197525 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84885618 |
| 93 | definitive hemopoiesis (GO:0060216) | 2.83908532 |
| 94 | regulation of prostaglandin secretion (GO:0032306) | 2.82226565 |
| 95 | mature B cell differentiation (GO:0002335) | 2.77118304 |
| 96 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76879124 |
| 97 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.76827847 |
| 98 | protein retention in ER lumen (GO:0006621) | 2.76228813 |
| 99 | cellular metabolic compound salvage (GO:0043094) | 2.76146041 |
| 100 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.76106644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.58546148 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.71947386 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84526619 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12608986 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.93162978 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.77299355 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65909699 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.61715240 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.53395008 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52433240 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46163308 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26915363 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.16228691 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.14111726 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.13890674 |
| 16 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.02363140 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.98693962 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.95071671 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90602397 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90277168 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89565927 |
| 22 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.87480952 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85777842 |
| 24 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81193549 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77420451 |
| 26 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.75495143 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.74256840 |
| 28 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69538014 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67451901 |
| 30 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.67264923 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66682991 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65530017 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64108319 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.63424955 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62297682 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61422667 |
| 37 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61213272 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60407600 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60380965 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.56866880 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54564962 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49981722 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.48921612 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48511516 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.46245770 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.46043134 |
| 47 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.46040072 |
| 48 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45624438 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40422275 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39756314 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39721731 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36674416 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.36393994 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32709367 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.32416080 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27512326 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26739797 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26588845 |
| 59 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25379160 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24983145 |
| 61 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.24772636 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23625207 |
| 63 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23257252 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22598817 |
| 65 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22263845 |
| 66 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20745337 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20120128 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18776554 |
| 69 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18238033 |
| 70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.16726043 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16709366 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14781976 |
| 73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13535427 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13404421 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13375582 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13198476 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12684007 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11648045 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11217178 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10747035 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10560329 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10047570 |
| 83 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08937294 |
| 84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06654805 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06292032 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04924263 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04815708 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03098060 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02479263 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00792690 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00439622 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 0.99153717 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98837599 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98221497 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97916522 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97059912 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95580186 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95342287 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94260711 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93444436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009697_abnormal_copulation | 4.56614826 |
| 2 | MP0005451_abnormal_body_composition | 4.07292180 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.56199266 |
| 4 | MP0009278_abnormal_bone_marrow | 3.46229859 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.85849645 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.85849645 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.72816897 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 2.30735772 |
| 9 | MP0003186_abnormal_redox_activity | 2.20700403 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.16047563 |
| 11 | MP0002822_catalepsy | 2.09714594 |
| 12 | MP0005670_abnormal_white_adipose | 2.07772446 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.07464764 |
| 14 | MP0005330_cardiomyopathy | 2.07299640 |
| 15 | MP0002234_abnormal_pharynx_morphology | 2.07259807 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.05173524 |
| 17 | MP0002132_abnormal_respiratory_system | 2.04493797 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.03887281 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.01949467 |
| 20 | MP0005464_abnormal_platelet_physiology | 1.97062316 |
| 21 | MP0003718_maternal_effect | 1.94975875 |
| 22 | MP0001764_abnormal_homeostasis | 1.91299060 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.83492813 |
| 24 | MP0000566_synostosis | 1.78418923 |
| 25 | MP0008932_abnormal_embryonic_tissue | 1.74383282 |
| 26 | MP0000358_abnormal_cell_content/ | 1.68802774 |
| 27 | MP0000462_abnormal_digestive_system | 1.62514784 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.62060972 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.59723455 |
| 30 | MP0001849_ear_inflammation | 1.52619102 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.50208519 |
| 32 | MP0008058_abnormal_DNA_repair | 1.48430735 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.45324456 |
| 34 | MP0008789_abnormal_olfactory_epithelium | 1.44915981 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.40660257 |
| 36 | MP0004147_increased_porphyrin_level | 1.40221737 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.40073281 |
| 38 | MP0002019_abnormal_tumor_incidence | 1.30796538 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.29182733 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.22873406 |
| 41 | MP0005165_increased_susceptibility_to | 1.18954683 |
| 42 | MP0002249_abnormal_larynx_morphology | 1.18007217 |
| 43 | MP0003786_premature_aging | 1.17666339 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.17365954 |
| 45 | MP0000490_abnormal_crypts_of | 1.17100024 |
| 46 | MP0005501_abnormal_skin_physiology | 1.16639127 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.14926247 |
| 48 | MP0001881_abnormal_mammary_gland | 1.14724609 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13479221 |
| 50 | MP0001664_abnormal_digestion | 1.12031656 |
| 51 | MP0003077_abnormal_cell_cycle | 1.10221346 |
| 52 | MP0003075_altered_response_to | 1.09379123 |
| 53 | MP0001529_abnormal_vocalization | 1.09348371 |
| 54 | MP0005499_abnormal_olfactory_system | 1.09041664 |
| 55 | MP0005394_taste/olfaction_phenotype | 1.09041664 |
| 56 | MP0000681_abnormal_thyroid_gland | 1.08186217 |
| 57 | MP0000751_myopathy | 1.04283489 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.01056301 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.00493351 |
| 60 | MP0004233_abnormal_muscle_weight | 0.99439124 |
| 61 | MP0000313_abnormal_cell_death | 0.99006636 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 0.97484130 |
| 63 | MP0000350_abnormal_cell_proliferation | 0.97073809 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.96094909 |
| 65 | MP0005384_cellular_phenotype | 0.95437941 |
| 66 | MP0005666_abnormal_adipose_tissue | 0.93672628 |
| 67 | MP0002080_prenatal_lethality | 0.90941702 |
| 68 | MP0000759_abnormal_skeletal_muscle | 0.90906190 |
| 69 | MP0005375_adipose_tissue_phenotype | 0.89568294 |
| 70 | MP0001905_abnormal_dopamine_level | 0.89483143 |
| 71 | MP0010386_abnormal_urinary_bladder | 0.86427846 |
| 72 | MP0002970_abnormal_white_adipose | 0.85508815 |
| 73 | MP0005621_abnormal_cell_physiology | 0.83881013 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.82384356 |
| 75 | MP0005083_abnormal_biliary_tract | 0.78371117 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.78097187 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.77929939 |
| 78 | MP0001730_embryonic_growth_arrest | 0.76473826 |
| 79 | MP0000858_altered_metastatic_potential | 0.75673743 |
| 80 | MP0002398_abnormal_bone_marrow | 0.75053959 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.74881642 |
| 82 | MP0004858_abnormal_nervous_system | 0.74572475 |
| 83 | MP0009931_abnormal_skin_appearance | 0.73776650 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.73584804 |
| 85 | MP0002722_abnormal_immune_system | 0.73137023 |
| 86 | MP0008770_decreased_survivor_rate | 0.72963333 |
| 87 | MP0002160_abnormal_reproductive_system | 0.72557180 |
| 88 | MP0000749_muscle_degeneration | 0.71968339 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.71813801 |
| 90 | MP0005334_abnormal_fat_pad | 0.70990617 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.70556291 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.70124103 |
| 93 | MP0000750_abnormal_muscle_regeneration | 0.69920757 |
| 94 | MP0002429_abnormal_blood_cell | 0.66312039 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 0.65347972 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.63868380 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.63180478 |
| 98 | MP0003948_abnormal_gas_homeostasis | 0.61603875 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.61357822 |
| 100 | MP0000516_abnormal_urinary_system | 0.60459983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.28947287 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.72098510 |
| 3 | B lymphocytopenia (HP:0010976) | 3.59090923 |
| 4 | Abnormality of B cell number (HP:0010975) | 3.43873988 |
| 5 | Increased muscle lipid content (HP:0009058) | 3.38656273 |
| 6 | Hypertensive crisis (HP:0100735) | 3.33097569 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.25723615 |
| 8 | Hydroureter (HP:0000072) | 3.23944600 |
| 9 | Progressive muscle weakness (HP:0003323) | 3.20866600 |
| 10 | Type I transferrin isoform profile (HP:0003642) | 3.17567370 |
| 11 | Cellulitis (HP:0100658) | 3.13431376 |
| 12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.11910250 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.10972782 |
| 14 | Opisthotonus (HP:0002179) | 3.07018281 |
| 15 | Urethral obstruction (HP:0000796) | 3.05089464 |
| 16 | Acute encephalopathy (HP:0006846) | 3.04132755 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.02835090 |
| 18 | Cerebral edema (HP:0002181) | 3.02031565 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 3.01693278 |
| 20 | Acute lymphatic leukemia (HP:0006721) | 2.99898007 |
| 21 | Hepatocellular necrosis (HP:0001404) | 2.99616922 |
| 22 | Exercise intolerance (HP:0003546) | 2.97893920 |
| 23 | Progressive external ophthalmoplegia (HP:0000590) | 2.94408319 |
| 24 | Multiple enchondromatosis (HP:0005701) | 2.92774823 |
| 25 | Ragged-red muscle fibers (HP:0003200) | 2.83705120 |
| 26 | Dicarboxylic aciduria (HP:0003215) | 2.82234542 |
| 27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82234542 |
| 28 | Increased CSF lactate (HP:0002490) | 2.80493085 |
| 29 | Easy fatigability (HP:0003388) | 2.79057992 |
| 30 | Abnormality of the columella (HP:0009929) | 2.73871775 |
| 31 | Microvesicular hepatic steatosis (HP:0001414) | 2.71000201 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67111002 |
| 33 | Progressive microcephaly (HP:0000253) | 2.66269414 |
| 34 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.65441127 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.61270900 |
| 36 | Truncus arteriosus (HP:0001660) | 2.60950482 |
| 37 | High anterior hairline (HP:0009890) | 2.53787168 |
| 38 | Hepatic necrosis (HP:0002605) | 2.53158698 |
| 39 | Granulocytopenia (HP:0001913) | 2.52447409 |
| 40 | Degeneration of anterior horn cells (HP:0002398) | 2.50151556 |
| 41 | Abnormality of the anterior horn cell (HP:0006802) | 2.50151556 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.50049182 |
| 43 | Trismus (HP:0000211) | 2.48550684 |
| 44 | Microretrognathia (HP:0000308) | 2.48263360 |
| 45 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.45386474 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.45386474 |
| 47 | Emotional lability (HP:0000712) | 2.39930771 |
| 48 | Petechiae (HP:0000967) | 2.37569990 |
| 49 | Increased IgE level (HP:0003212) | 2.37499088 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.35249900 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.35249900 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.35249900 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.35249900 |
| 54 | Lactic acidosis (HP:0003128) | 2.34396099 |
| 55 | Stridor (HP:0010307) | 2.32613021 |
| 56 | Testicular atrophy (HP:0000029) | 2.29196619 |
| 57 | Hyperglycinemia (HP:0002154) | 2.28219802 |
| 58 | Hyperthyroidism (HP:0000836) | 2.27170511 |
| 59 | Respiratory failure (HP:0002878) | 2.26899690 |
| 60 | Distal lower limb amyotrophy (HP:0008944) | 2.26472139 |
| 61 | Progressive macrocephaly (HP:0004481) | 2.25217933 |
| 62 | Abnormal pupillary function (HP:0007686) | 2.24548773 |
| 63 | Lethargy (HP:0001254) | 2.23403201 |
| 64 | Muscle fiber atrophy (HP:0100295) | 2.22203297 |
| 65 | Death in childhood (HP:0003819) | 2.22001952 |
| 66 | Cerebral palsy (HP:0100021) | 2.20429676 |
| 67 | External ophthalmoplegia (HP:0000544) | 2.17864900 |
| 68 | Orthostatic hypotension (HP:0001278) | 2.17707726 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.16926826 |
| 70 | Xerostomia (HP:0000217) | 2.15800415 |
| 71 | Cupped ribs (HP:0000887) | 2.11361998 |
| 72 | Thrombocytosis (HP:0001894) | 2.11151288 |
| 73 | Reticulocytosis (HP:0001923) | 2.08687869 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08596817 |
| 75 | Fragile skin (HP:0001030) | 2.05461466 |
| 76 | Abnormality of the umbilical cord (HP:0010881) | 2.02407517 |
| 77 | Brushfield spots (HP:0001088) | 2.00399923 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99318906 |
| 79 | Joint stiffness (HP:0001387) | 1.98651121 |
| 80 | J-shaped sella turcica (HP:0002680) | 1.98081949 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 1.97050342 |
| 82 | Increased serum lactate (HP:0002151) | 1.96826051 |
| 83 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.96546946 |
| 84 | Hyperammonemia (HP:0001987) | 1.95834889 |
| 85 | Hepatosplenomegaly (HP:0001433) | 1.94279038 |
| 86 | Mesangial abnormality (HP:0001966) | 1.93891237 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 1.92265067 |
| 88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92081901 |
| 89 | Retinal dysplasia (HP:0007973) | 1.90492745 |
| 90 | Hypoparathyroidism (HP:0000829) | 1.90287221 |
| 91 | Seborrheic dermatitis (HP:0001051) | 1.89502803 |
| 92 | Abnormality of reticulocytes (HP:0004312) | 1.85485614 |
| 93 | Abnormality of the tricuspid valve (HP:0001702) | 1.85103455 |
| 94 | Broad distal phalanx of finger (HP:0009836) | 1.84720474 |
| 95 | Sepsis (HP:0100806) | 1.82671975 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.82080674 |
| 97 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.81872392 |
| 98 | Aplastic anemia (HP:0001915) | 1.81304218 |
| 99 | 11 pairs of ribs (HP:0000878) | 1.80313491 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.78958086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.28938055 |
| 2 | SCYL2 | 5.44252959 |
| 3 | VRK2 | 4.93540773 |
| 4 | KDR | 4.40231306 |
| 5 | TESK2 | 4.36179944 |
| 6 | TESK1 | 3.07067923 |
| 7 | NME2 | 2.77472074 |
| 8 | PIM2 | 2.53666936 |
| 9 | PBK | 2.51649055 |
| 10 | FLT3 | 2.48004807 |
| 11 | ERN1 | 2.36710717 |
| 12 | NUAK1 | 2.36650983 |
| 13 | IRAK3 | 2.13664145 |
| 14 | MST1R | 2.01055128 |
| 15 | LIMK1 | 1.87262069 |
| 16 | MAP3K11 | 1.61588525 |
| 17 | IRAK2 | 1.51116369 |
| 18 | SIK1 | 1.44204588 |
| 19 | VRK1 | 1.41667787 |
| 20 | SMG1 | 1.32978576 |
| 21 | CDK19 | 1.20455183 |
| 22 | ABL2 | 1.17584741 |
| 23 | EPHA2 | 1.15590182 |
| 24 | TBK1 | 1.12959168 |
| 25 | KIT | 1.02582385 |
| 26 | TAOK1 | 1.00082827 |
| 27 | TAOK3 | 0.95398114 |
| 28 | DAPK1 | 0.87737268 |
| 29 | EIF2AK1 | 0.86138436 |
| 30 | AURKA | 0.84978995 |
| 31 | MET | 0.83723571 |
| 32 | RAF1 | 0.83382133 |
| 33 | CHEK2 | 0.83230433 |
| 34 | STK16 | 0.82780375 |
| 35 | CDK7 | 0.82048547 |
| 36 | ZAK | 0.79261962 |
| 37 | TIE1 | 0.72716871 |
| 38 | RPS6KB2 | 0.70485511 |
| 39 | GRK6 | 0.68364334 |
| 40 | ATR | 0.67968288 |
| 41 | RPS6KA4 | 0.66842757 |
| 42 | TTN | 0.64070757 |
| 43 | MAP4K2 | 0.63891807 |
| 44 | PAK4 | 0.63154462 |
| 45 | CSF1R | 0.62525222 |
| 46 | AURKB | 0.60971509 |
| 47 | TAOK2 | 0.60527715 |
| 48 | PKN2 | 0.55493795 |
| 49 | PIK3CG | 0.52809825 |
| 50 | BMX | 0.51640587 |
| 51 | CDK4 | 0.50183547 |
| 52 | MAP4K1 | 0.48740551 |
| 53 | CSNK1G3 | 0.47791463 |
| 54 | PAK2 | 0.46899087 |
| 55 | CDK9 | 0.46243829 |
| 56 | TRIB3 | 0.45533877 |
| 57 | ARAF | 0.45049208 |
| 58 | CDC7 | 0.44705183 |
| 59 | AKT2 | 0.43486620 |
| 60 | DYRK2 | 0.42769986 |
| 61 | IKBKB | 0.41371489 |
| 62 | RPS6KA5 | 0.40905079 |
| 63 | PRKD2 | 0.37515271 |
| 64 | MAP2K7 | 0.37267090 |
| 65 | MAP2K2 | 0.37071058 |
| 66 | CCNB1 | 0.36837171 |
| 67 | TAF1 | 0.35911663 |
| 68 | MAP3K1 | 0.35124724 |
| 69 | MAPKAPK2 | 0.34352579 |
| 70 | CAMK2G | 0.33578921 |
| 71 | CHEK1 | 0.32913224 |
| 72 | DAPK3 | 0.32786829 |
| 73 | NEK1 | 0.32559971 |
| 74 | MOS | 0.32009651 |
| 75 | CLK1 | 0.31972041 |
| 76 | RET | 0.31911728 |
| 77 | GRK7 | 0.31365193 |
| 78 | GRK5 | 0.31254253 |
| 79 | EIF2AK2 | 0.30974070 |
| 80 | CSNK2A2 | 0.28719020 |
| 81 | CSNK1A1L | 0.28530556 |
| 82 | MATK | 0.28259189 |
| 83 | CDK8 | 0.28175055 |
| 84 | LMTK2 | 0.28121047 |
| 85 | CSNK1G1 | 0.27811137 |
| 86 | MAPK11 | 0.27091973 |
| 87 | MAPKAPK5 | 0.26162233 |
| 88 | MAP3K6 | 0.25049235 |
| 89 | GSK3A | 0.23878675 |
| 90 | PRKD1 | 0.23873222 |
| 91 | PAK1 | 0.23690003 |
| 92 | LRRK2 | 0.23558093 |
| 93 | DYRK3 | 0.23498701 |
| 94 | MKNK1 | 0.23050655 |
| 95 | MAP3K8 | 0.22968763 |
| 96 | PRKCI | 0.22847703 |
| 97 | MTOR | 0.22469872 |
| 98 | CDK11A | 0.22076539 |
| 99 | CDK2 | 0.21649861 |
| 100 | MUSK | 0.21390024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.96485745 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.72106117 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.15274620 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.13935981 |
| 5 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.79517937 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.37422293 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.33853299 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.25986865 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.23984426 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.22464153 |
| 11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.19406339 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17383199 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.08213172 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95938227 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95462169 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93008737 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88854115 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.86594772 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.86440022 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.84446753 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.83323837 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.80614292 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.80542441 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.67121370 |
| 25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.66936420 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66923887 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.61229876 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59821059 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58997441 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58429742 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51156603 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.47831349 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.46395651 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.44083242 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40928953 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37496720 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35470541 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.25192864 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17446301 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12969631 |
| 41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12663588 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.11322283 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10280417 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06852254 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00968578 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.00429843 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.00321629 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96070278 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93656539 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92469845 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91202566 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89959715 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.89331334 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88435252 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87121940 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86355514 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85541850 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83269964 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79235791 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78602033 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75753397 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75418630 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73169287 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72914618 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68012137 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.67269197 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66620055 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59634477 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57750941 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.52758690 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.51424786 |
| 72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50646330 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49837242 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49559030 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47522846 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47215229 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44543993 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42821769 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42723514 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39732357 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38478400 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37758593 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31572141 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29609648 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28810919 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27302696 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25288801 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.25044984 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24885120 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24533282 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24373154 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24015997 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22418465 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20049653 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.19420249 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19271116 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17679761 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15633534 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.14407149 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.13913844 |

